Who would I report to? http://tnaflix.in.net/ tnaflix.com Volasertib is a polo-like kinase (Plk) inhibitor,and Boehringer’s head of medicine, Klaus Dugi, says that its "innovative mode of action offers a new approach and may potentially provide a new therapy option for AML patients who have a high unmet medical need”. AML accounts for about one-third of all adult leukaemias in the western world and has one of the lowest survival rates.
PUEBLO CONTINENTE
yZbQvCzuzBubbeU
"Florencio" (2019-07-19)
En respuesta a Marie Sklodowska Curie
Who would I report to? http://tnaflix.in.net/ tnaflix.com Volasertib is a polo-like kinase (Plk) inhibitor,and Boehringer’s head of medicine, Klaus Dugi, says that its "innovative mode of action offers a new approach and may potentially provide a new therapy option for AML patients who have a high unmet medical need”. AML accounts for about one-third of all adult leukaemias in the western world and has one of the lowest survival rates.| Enviar respuesta
Añadir comentario